Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Fischer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biomedical Sciences Instrumentation|January 1, 1990
A Monte Carlo simulation of range for an invasive impedance respiration monitorH L Valenta, S K Fischer
Biomedical Sciences Instrumentation|January 1, 1987
Rate responsive pacing compromise: response time vs. heart rat variationH L Valenta, S K Fischer, J C Hansen
Physics in Medicine and Biology|September 25, 1999
Computer-guided laser probe for ablation of brain tumours with ultrashort laser pulsesM H Goetz, S K Fischer, A Velten, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-CD4 monoclonal antibody from preclinical model to phase I studyY Zheng, H Scheerens, J C Davis, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biomedical Sciences Instrumentation|January 1, 1990
A Monte Carlo simulation of range for an invasive impedance respiration monitorH L Valenta, S K Fischer
Biomedical Sciences Instrumentation|January 1, 1987
Rate responsive pacing compromise: response time vs. heart rat variationH L Valenta, S K Fischer, J C Hansen
Physics in Medicine and Biology|September 25, 1999
Computer-guided laser probe for ablation of brain tumours with ultrashort laser pulsesM H Goetz, S K Fischer, A Velten, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-CD4 monoclonal antibody from preclinical model to phase I studyY Zheng, H Scheerens, J C Davis, et al.
Pageof 1